Steven Cohen Ironwood Pharmaceuticals Inc Transaction History

Point72 Asset Management, L.P.

$42.2 Billion
Q4 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,151,008 shares of IRWD stock, worth $2.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,151,008

Holding current value

$2.09 Million

% of portfolio

0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$3.34 - $5.04 $3.84 Million - $5.8 Million	1,151,008 New	1,151,008 $5.1 Million
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $8.61 Million - $11.3 Million	979,896 Added 79.17%	2,217,669 $25.4 Million
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $873,625 - $1.2 Million	105,894 Added 9.36%	1,237,773 $11.9 Million
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $11.3 Million - $13 Million	1,121,686 Added 11004.47%	1,131,879 $12 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $105,701 - $128,024	10,193 New	10,193 $107,000
Q1 2021 May 17, 2021	SELL	$9.04 - $11.86 $5.61 Million - $7.35 Million	-620,139 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $5.61 Million - $7.57 Million	620,139 New	620,139 $7.06 Million
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $685,653 - $1.12 Million	-79,913 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $656,884 - $1.12 Million	79,913 New	79,913 $1.06 Million
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $297,960 - $616,166	-38,200 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$14.31 - $17.65 $15 Million - $18.5 Million	-1,046,906 Reduced 96.48%	38,200 $705,000
Q2 2018 Aug 14, 2018	BUY	$11.83 - $16.2 $12.1 Million - $16.5 Million	1,020,106 Added 1569.39%	1,085,106 $20.7 Million
Q1 2018 May 15, 2018	BUY	$11.13 - $13.63 $723,450 - $885,950	65,000 New	65,000 $1 Million

Others Institutions Holding IRWD

# of Institutions

243

Shares Held

163M

Call Options Held

11.5M

Put Options Held

12.9K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $279M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account